Office-Based Diagnosis of Demodex Using Smartphone.

Eye Contact Lens

Department of Ophthalmology, Diskapi Yildirim Beyazit Education and Training Hospital, University of Health Sciences, Ankara, Turkey.

Published: November 2018

Demodex is an important pathogen in ophthalmology. It is believed to cause a variety of eyelid and eyelash diseases. Currently, light microscopes are being used for imaging demodex. However, microscopes are not available everywhere. Also, it is not cost-effective to perform light microscopy in every case. In this case, we demonstrate a new method: imaging demodex using cell phone. A 90-diopter noncontact double aspheric lens was attached to the posterior camera of the smartphone with clear tape. An eyelash of a patient with blepharitis was removed. A video was taken using smartphone. There was a moving demodex parasite in the root of the eyelash. A clear video image could be taken using the smartphone. A smartphone and a 90-diopter lens are adequate for the imaging and diagnosis of demodex.

Download full-text PDF

Source
http://dx.doi.org/10.1097/ICL.0000000000000507DOI Listing

Publication Analysis

Top Keywords

diagnosis demodex
8
imaging demodex
8
demodex
6
smartphone
5
office-based diagnosis
4
demodex smartphone
4
smartphone demodex
4
demodex pathogen
4
pathogen ophthalmology
4
ophthalmology believed
4

Similar Publications

Background Topical steroid-dependent or damaged face (TSDF) is a common condition where the widespread availability of over-the-counter topical corticosteroid (TCS)-containing products leads to their misuse and addiction. Prolonged use of these steroids on the face can result in significant side effects. Early diagnosis and cessation of steroid use are important.

View Article and Find Full Text PDF

Demodex and the eye - A review.

Indian J Ophthalmol

January 2025

Cornea, Cataract and Refractive Surgery, Darshan Eye Clinic and Surgical Centre, Chennai, Tamil Nadu, India.

Demodexblepharitis (DB) has become one of the common differential diagnoses in patients presenting with red eyes in daily clinics. In this review article, we have incorporated a detailed discussion about the mite and the various mechanisms by which it causes different signs and symptoms, the risk factors, and diagnostic methods with current and emerging treatment modalities. Because of the chronic symptoms and rather a late diagnosis, DB considerably affects patients' quality of life.

View Article and Find Full Text PDF

Topical Ivermectin-metronidazole gel therapy improves Meibomian gland Function in blepharitis caused by demodex spp.

Cont Lens Anterior Eye

December 2024

Department of Ophthalmology, Molecular Pharmacology and Physiology, FL, United States; Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.

Purpose: To evaluate the efficacy and safety of topical Ivermectin- Metronidazol in the management of demodex infestation and their effect in Meibomian gland dysfunction (MGD) METHODS: Fifty-four patients (108 eyes) with demodex diagnosis and Meibomian gland dysfunction received Ivermectin 0.3 %+Metronidazole 0.5 % gel in the night for 5 weeks.

View Article and Find Full Text PDF

The Effect of Terpinen-4-ol on Human Corneal Epithelium.

Transl Vis Sci Technol

December 2024

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Purpose: To investigate the toxicity of terpinen-4-ol (T4O) on primary cultured human corneal epithelial cells (HCECs).

Methods: HCECs were exposed to various concentrations (0%-0.1%) of T4O for 15 minutes to 72 hours.

View Article and Find Full Text PDF
Article Synopsis
  • Dermatologists struggle with treating demodicosis due to its recurrence and difficulty in normalizing densities even after improvement.
  • The study evaluated the effectiveness of oral ivermectin (200 µg/kg/week) in improving clinical symptoms and reducing density in 40 demodicosis patients, comparing those with lower and higher densities.
  • Results showed 75% of patients achieved clinical remission, with quicker remission for patients with lower densities (28 days) compared to those with higher densities (56 days).
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!